Dr Stanislaw Bursynski has been curing cancer (with no side-effects) for over 30 years at his clinic in Houston, Texas. The FDA has been trying to shut him down for the entire duration, because even though he is curing cancer, he's not using an "approved" method. In other words, his protocol does not require chemotherapy, and Big Pharma does not like competition. In an attempt to discredit Dr Burzynski, the FDA outsourced a clinical trial to a non-Burzynski clinic and purposely did not follow his protocol so the results were poor. A "peer reviewed" paper was then written declaring that his protocol does not work. Thus, doctors reading medical journals are misinformed as to Dr Burzynski's success in reversing cancer. And the kicker is that, all the while the US government was trying to arrest and discredit him, they were also secretly trying to steal his patent, by submitting multiple patents for his protocol, for which he had already received a patent. They know it works! The judge even stated that whether his protocol works or not, is not relevant to the case! Learn about his cure and his legal battles with the FDA in the award-winning documentary "Burzynski - Cancer is Serious Business".

The FDA has been doing the same thing to Dr Rashid Buttar in North Carolina.

Dr Burzynski a Threat to the Cancer Industry

"What made Dr Burzynski a threat to the cancer industry from the beginning was the prospect that antineoplaston therapy represented a successful alternative to toxic and dangerous chemotherapy drugs, upon which most of the cancer industry's profits depend. Did the NCI pick up the tab for completing his research? Did the ACS help with favourable publicity? Of course not. The minute NCI saw evidence of antineoplastons working they distorted the data by withdrawing the 2 successful patients and thus the evidence. NCI's conduct towards him is a striking example of how an agency presumed to be objective can set up a study that will either prove or disprove anything it wants. In this case, there is clear evidence that NCI wanted to prove antineoplastons didn't work."--John Diamond, M.D. & Lee Cowden, M.D.

"Typical of Burzynski's extraordinary results were the outcomes for early groups of advanced cancer patients treated with antineoplastons: 60 percent enjoyed objective remission, 47 percent experienced complete remission, and 20 percent survived for over five years without cancer. These and other results are far superior to anything reported then or now for standard cancer treatments. (For example, in 1985 interleukin-2 was heavily promoted by orthodoxy, supposedly as a highly promising new treatment after a single study showed it to have been associated with a complete remission from cancer in only one patient out of twenty-four treated -- a positive response rate of only fourpercent!)."--Barry

"Without exception, all the oncologists I talked to about Dr Burzynski were scornful and hostile. Twenty- five years of practicing unconventional medicine did not prepare me for what I discovered. Delving into attitudes, actions, and beliefs of modern oncologists was like opening a box of cereal and finding it full of worms. They just don’t care. The question I kept asking was why, and the answer to that question gradually began to creep out: Dr Burzynski's discovery threatens one of the largest and most lucrative industries in the history of mankind, the cancer treatment industry.

All those radiation machines and doctors who run them...
All those chemotherapy drugs and the doctors who prescribe them...
All those so called studies that just juggle the doses of chemo and radiation, and
All those surgeons who have been flailing at cancer for over a 100 years.

If it (antineoplastons) is allowed to flourish, it renders obsolete the entire cancer treatment industry. He has discovered a non-toxic treatment that is about as close to cure as we have ever seen. If you think the lumber jacks in the Pacific Northwest were scornful of the spotted owl, you haven't seen anything yet.

Also it is not just about money, it is about strongly held beliefs, beliefs that have meshed with the personality of virtually everyone in the cancer treatment industry, especially the physicians. In short, these beliefs are that cancer can only be treated with therapies that mutilate, poison, or burn the patient, in the hope that they "kill" the cancer. Therefore, each patient who is miraculously cured by Burzynski's nontoxic therapy is not viewed as a breakthrough, or even as something good, but rather as a dangerous messenger of heresy, a terrible threat to their beliefs." --Dr Julian Whitaker M.D.

"Don't take this therapy lightly. Multiple sclerosis, colitis, lupus, rheumatoid arthritis, cancer, hepatitis, hyperactivity, pancreatic insufficiency, psoriasis, eczema, diabetes, herpes, mononucleosis, adrenal failure, allergies and so many other ailments have been relieved through use of this therapy. After you overcome your initial gag response (I know I had one), you will realize that something big is going on, and if you are searching for health, this is an area to investigate. There are numerous reports and double blind studies which go back to the turn of the century supporting the efficacy of using urine for health. More on urine therapy

Chemo NOT a Cure: "Survival" After Chemo Defined as "Still Alive Five Years Later" (Not "Cancer-Free")

For the 33% who outright die from the chemo, their quality of life in those final months is hellish. And for the 67% who "survive" chemo, they usually have permanent brain, heart and/or kidney damage, and a greatly reduced life expectancy due to those problems and/or the cancer returning. Also, DNA damage you receive from chemotherapy will be passed on to your offspring; that is, if you are not rendered sterile from the chemo itself. These issues are explained very well in this article at Green Med Info.

Note: Doctors receive a substantial financial incentive for each patient they enroll in chemo. That will help you understand their vehement objections when you refuse it!

Study: The Contribution of Cytotoxic Chemotherapy to 5-year Survival in Adult Malignancies

This groundbreaking 14 year study was published in the Journal of Clinical Oncology in December 2004.

Researchers at the Department of Radiation Oncology at the Northern Sydney Cancer Centre studied the 5-year survival rates of chemotherapy on 22 types of cancers in the US and Australia. They studied 154,971 Americans and Australians with cancer, age 20 and older, that were treated with conventional treatments, including chemotherapy.

Only 3,306 had survival that could be credited to chemotherapy. Study Results: "The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1 % in The USA"

Study Conclusion: "As the 5-year survival rate in Australia is now over 60%, it is clear that cytotoxic chemotherapy only makes a minor contribution to cancer survival. To justify the continued funding and availability of drugs used in cytotoxic chemotherapy, a rigorous evaluation of the cost-effectiveness and impact on quality of life is urgently required."

The fact that chemo only contributes on average about 2% to the overall survival rate is very alarming, and probably something your doctors didn't tell you.

It is important to remember that the "2.1% average" can be deceptive. Some cancers do respond better to chemo than others.

According to this research, the best results from chemotherapy are treating testicular Cancer where it is 41.8% effective, and Hodgkins Disease where it is 35.8% effective. Still not great.

You can read and download the entire study in PDF format here: Chris Beat Cancer

Even if you think you're not interested in the topic of AIDS, Gary Null's documentary below is MUST SEE! In it, you'll learn that chemotherapy (which is indescriminate DNA chain termination) is known to have only destructive effects, but is given anyway because it's a big money maker. It was developed based on the theory of 30 years ago that cancer is caused by a retro-virus. Chemo drugs do not target cancer cells, but terminate the normal cellular repair mechanism in ALL cells, and eventually the patient will die, because all cells must repair themselves on a continual basis. A new study shows that chemo makes tumors grow faster! And AZT is chemo. See Janine Roberts' book: Fear of the Invisible and also Ten Lies of AIDS by Etienne De Harven.

Cancer and Alkalinity

PUBLIC RELEASE: 25-JAN-2013 Tumor cells engineer acidity to drive cell invasion, Moffitt Cancer Center researchers say using buffers to increase pH may inhibit cancer growth. - H. Lee Moffitt Cancer Center & Research Institute

Researchers at Moffitt Cancer Center and colleagues at Wayne State University School of Medicine investigated the acidity in solid tumors to determine if pH levels play a role in cancer cell invasion in surrounding tissues. They found that an acidic microenvironment can drive cancer cells to spread and propose that neutralizing pH would inhibit further invasion, providing a therapeutic opportunity to slow the progression of cancers.

Their study appeared in the Jan. 3 online release of Cancer Research, a publication of the American Association for Cancer Research. According to the study's corresponding author, Robert J. Gillies, Ph.D., chair of the Department of Cancer Imaging & Metabolism at Moffitt, acidity in solid tumors is the result of an increased fermentative metabolism combined with poor delivery of blood to tissues. In this study, tumor invasion and pH were monitored in immunodeficient laboratory mice hosting a variety of tumors. "We monitored the test animals over time using microscopy and found that the highest regions of tumor invasion corresponded to areas with the lowest pH," Gillies explained. "Tumor invasion did not occur in regions with normal or near normal pH levels. Furthermore, when we neutralized the acidity with oral sodium bicarbonate, the invasion was halted."

Researchers proposed that the acidic pH of the tumor microenvironment represents a "niche engineering" strategy on the part of tumor cells, promoting invasion and growth of malignant tumors into surrounding tissue. Niche engineering is a concept in ecology describes how plants and animals alter their environment to in ways that promote their own growth and survival over their competitors. "We have long regarded cancers cells as an invading species," said study co-author Robert Gatenby, M.D., chair of the Diagnostic Imaging Services and Integrated Mathematical Oncology departments at Moffitt.

A key to this process of adaptation and invasion is increased glucose metabolism in the tumor. "The vast majority of malignant tumors metabolize glucose at high rates," Gillies said. "We have proposed that there is a direct, causative link between increased glucose metabolism and the ability of cancer cells to invade and metastasize."

According to the research, elevated glucose metabolism is the cause of increased acidity in the tumor microenvironment. Most tumors develop an abnormal vascular network that tends to be poorly organized and leaky, disrupting blood flow and hampering the delivery of oxygen.

"This poorly organized vascular system has a two-fold effect on tumor acidity," explained Gatenby. "First, it subjects tumor regions to poor perfusion, which restricts oxygen and increases the rate of glucose fermentation. Second, the poor perfusion hampers the ability to eliminate the resulting acids, resulting in very low pH in surrounding tissues."

As tumor cells adapt to increasing acidity, niche engineering through normal cell death and new blood vessel formation occurs in the tumor and the immune response is suppressed.

"Tumor cells perform niche engineering by creating an acidic environment that is not toxic to the malignant cells but, through its negative effects on normal cells and tissues, promotes local invasion of malignant cells," Gatenby said. The researchers suggested that targeting this activity with buffers and other mechanisms aimed at increasing pH levels will likely provide a valuable alternative to traditional therapies focused entirely on killing tumor cells.

Funding for this study came from federal grants U54 CA143970; R01 CA 077575; R01 CA 131990S.

About Moffitt Cancer Center: Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt's excellence in research, its contributions to clinical trials, prevention and cancer control. Since 1999, Moffitt has been listed in U.S. News & World Report as one of "America's Best Hospitals" for cancer. With more than 4,200 employees, Moffitt has an economic impact on the state of nearly $2 billion. For more information, visit MOFFITT.org, and follow the Moffitt momentum on Facebook, twitter and YouTube. Media release by Florida Science Communications.

Source: AAAS.org and EurekAlert!

"My studies have proved conclusively that untreated cancer victims live up to four times longer than treated individuals. If one has cancer and opts to do nothing at all, he will live longer and feel better than if he undergoes radiation, chemotherapy or surgery, other than when used in immediate life-threatening situations."---Prof Hardin Jones. (1956 Transactions of the N.Y. Academy of Medical Sciences, vol 6. There is a fifty page article by Hardin Jones of National Cancer Institute of Bethesda, Maryland. He surveyed global cancer of all types and compared the untreated and the treated, to conclude that the untreated outlives the treated, both in terms of quality and in terms of quantity. Secondly he said, "Cancer does not cure". Third he said "There is a physiological mechanism which finishes off an individual".) More: Dr Richard Shulze, N.D., M.H. and Chemo Genocide

Former professor of medical physics and physiology, at the University of California, Dr. Hardin B. Jones has treated cancer patients for more than 25 years and he studied their life expectancy. After long 25 years of studies, he came up to a conclusion that chemotherapy doesn't work.

Dr. Hardin B. Jones says that chemotherapy patients often die a painful and terrible death. Chemotherapy patients usually die much faster and more painfully than the other patients, who have selected different treatment for their disease. He found out that chemotherapy actually shortened the life and killed patients, and it's all kept in secret, because the pharmaceutical industry is making millions of dollars every day.In his study, published in the New York Academy of Science, Dr. Jones said the people who refused chemotherapy lived 12 years longer than the people who chose chemotherapy as a treatment for their cancer condition. He also says that a lot of people who accepted the chemotherapy died within 3 years, and many people died just a few weeks after starting the treatment. Breast cancer patients who didn't accept the chemotherapy lived 4 times longer than those who accepted chemotherapy as their treatment. More: Rethinking Cancer